Oncology, Pharmacology & Biotechnology

Drug Repurposing, Systematic Reviews, and Biotechnology.

General Research Overview: My research in this category encompasses a broad spectrum of translational medicine, focusing on therapeutic efficacy, metabolic regulation, and industrial biotechnology. I utilize systematic reviews and meta-analyses to evaluate the clinical performance of novel oncology treatments, such as Polatuzumab Vedotin, while simultaneously exploring metabolic targets like lysine malonylation for inflammatory and oncological disorders.

Core Areas of Impact:

Clinical Meta-Analysis & Evidence-Based Medicine: lead systematic evaluations of targeted therapies, specifically assessing the efficacy of Polatuzumab Vedotin in treating Non-Hodgkin Lymphoma.
Metabolic & Regulatory Research: explore lysine malonylation as a promising therapeutic target.
Pharmaceutical Analysis & Drug Repurposing: developed and validated RP-HPLC methods and explored the repurposing of drugs like Sofosbuvir.
Industrial Biotechnology: optimizing biocatalytic processes and bioremediation of pesticides through microbial mediators.
Biomaterials & Therapeutics: development of biopolymers for advanced medical applications like wound healing.

Technical Expertise:

Synthesis & Validation: Advanced skills in RP-HPLC method development and validation.
Bio-Informatics & Evidence Synthesis: Expertise in performing rigorous systematic reviews and meta-analyses.
Microbial Biotechnology: Proficiency in utilizing microbial systems for bioproduction and bioremediation.